anti-mTOR, mAb (53E11)

CHF 322.00
In stock
YIF-LF-MA0365100 µlCHF 322.00
More Information
Product Details
Synonyms mTOR; MTOR; FRAP; EC=2.7.11.1; Rapamycin Target Protein 1; Mammalian Target of Rapamycin; Rapamycin and FKBP12 target 1; Mechanistic Target of Rapamycin; Serine/Threonine-Protein Kinase mTOR
Product Type Monoclonal Antibody
Properties
Clone 53E11
Isotype Mouse IgG1 κ
Immunogen/Antigen Recombinant human His-mTOR protein purified from E. coli.
Application

Western Blot (1:2,000)

Crossreactivity Human
Formulation Liquid. HEPES with 0.15M NaCl, 0.01% BSA, 0.03% sodium azide, and 50% glycerol.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by AbFrontier
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS No
Product Specification Sheet
Datasheet Download PDF

Mammalian target of rapamycin (mTOR), a serine/threonine kinase involved in diverse cellular processes, including protein translation, mRNA turnover, and protein stability, mediates, at least in part, some of the biological actions of Akt. As a Kinase subunit of both mTORC1 (complex1) and mTORC2 (complex2), mTOR regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino-acids. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation. Kinase subunit of both mTORC1 and mTORC2, which regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino-acids. Growth factor-stimulated mTORC1 activation involves AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Amino-acid-signaling to mTORC1 requires its relocalization to the lysosomes mediated by the Ragulator complex and the Rag GTPases. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-421', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. Phosphorylates MAF1 leading to attenuation of its RNA polymerase III-repressive function. mTORC2 is also activated by growth. factors, but seems to be nutrient-insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'.

Product References

1) Sukumari-Ramesh S. Et al. (2011) Surg. Neurol. Int. 23;2:22. (General)
2) Dufner A., Thomas G. (1999) Exp. Cell Res. 253:100–109. (General)
3) Gingras A.C. Et al. (1998) Genes Dev. 12:502–13. (General)
4) Mamane Y. Et al. (2006) Oncogene. 25:6416–22. (General)
5) Kim D.-H. Et al. (2002) Cell 110:163-175. (General)
6) Hara K. Et al. (2002) Cell 110:177-189. (General)
7) Kim D.-H. Et al. (2003) Mol. Cell 11:895-904. (General)
8) Sarbassov D.D. Et al. (2004) Curr. Biol. 14:1296-1302. (General)
9) Jacinto E. Et al. (2004) Nat. Cell Biol. 6:1122-1128. (General)
10) Sarbassov D.D. Et al. (2005) Science 307:1098-1101. (General)
11) Garcia-Martinez J.M., Alessi D.R. (2008) Biochem. J. 416:375-385. (General)
12) Sancak Y. Et al. (2008) Science 320:1496-1501. (General)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.